Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather Jacene, Isabel T Rubio, Jan W Schoones, Marie-Jeanne Vrancken Peeters, Philip Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee de Geus-Oei
INTRODUCTION: There is much literature about the role of 2-[18 F]FDG PET/CT in patients with breast cancer (BC). However, there exists no international guideline with involvement of the nuclear medicine societies about this subject. PURPOSE: To provide an organized, international, state-of-the-art, and multidisciplinary guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and representation of important societies in the field of BC (ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)...
May 14, 2024: European Journal of Nuclear Medicine and Molecular Imaging